New drug cocktail shows promise for rare HIV-Linked cancer

This early-phase trial tested whether combining two anti-cancer drugs, pomalidomide (taken as a pill) and liposomal doxorubicin (given through an IV), is safe and tolerable for people with advanced or hard-to-treat Kaposi sarcoma. The study enrolled 62 adults, including those with HIV. The main goal was to find the best dose and check for side effects, while also looking at how the drugs affect quality of life and lung function.